Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.54 USD | -0.48% |
|
+19.00% | 0.00% |
15/04 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
15/04 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
47Cr | - | - | - | - | - | |
12TCr | ||||||
11TCr | ||||||
2.29TCr | - | |||||
2.22TCr | - | |||||
1.7TCr | - |